A novel angiogenesis inhibitor bevacizumab induces apoptosis in the rat endometriosis model.
Our aim was to investigate the effects of anti-vascular endothelial growth factor (anti-VEGF) antibody Bevacizumab on endometrial explants and on apoptotic gene expression levels in the rat endometriosis model. Endometriotic implants were surgically formed, and rats treated with (i) 1 mg/kg single subcutaneous injection of depot leuprolide acetate; (ii) 2.5 mg/kg of single intaperitoneal injection of bevacizumab; (iii) intraperitoneal injection of saline. Histopathologic scores and adhesion scores of endometriotic foci and levels of Bcl-2-associated X protein (Bax), Cytochrome c (Cyt-c), B-cell lymphoma/leukemia 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-xl) mRNA gene expressions of endometriotic foci. Bevacizumab treatment decreased the endometriotic explant size compared with control. Bevacizumab-treated rats had lower total adhesion scores when compared with the control group. Semi-quantitative evaluation of the persistence of endometrial epithelial cells in the explants showed a lower score in gonadotropin-releasing hormone (GnRH) agonist-treated rats compared with control rats. In Bevacizumab increased expression of Bax 3.1-fold, Cyt-c 1.3-fold and decreased expression of Bcl-2 0.4-fold, Bcl-xl 0.8-fold compared with the control group. The GnRH agonist increased expression of Bax 3.0 fold, Cyt-c 1.3 fold and decreased expression of Bcl-2 0.4-fold, Bcl-xl 0.8-fold, compared with the control group. This study suggests that a novel angiogenesis inhibitor, anti-VEGF antibody bevacizumab is as effective as GnRH agonist in the regression of the endometriotic lesions in rat endometriosis model. One possible mechanism of this effect is the induction of apoptosis.
Dokuz Eylül University, Obstetrics and Gynecology, 35340, İzmir, Turkey.
D
D
Soysal
Dokuz Eylül University, Medical Biology and Genetics, 35340, İzmir, Turkey.
S
S
Kızıldağ
Dokuz Eylül University, Obstetrics and Gynecology, 35340, İzmir, Turkey.
B
B
Saatlı
Dokuz Eylül University, Obstetrics and Gynecology, 35340, İzmir, Turkey.
C
C
Posacı
Menemen State Hospital, Obstetrics and Gynecology, 35660, İzmir, Turkey.
S
S
Soysal
Dokuz Eylül University, Pathology, 35340, İzmir, Turkey.
M
M
Koyuncuoğlu
Dokuz Eylül University, Obstetrics and Gynecology, 35340, İzmir, Turkey.
Öe
Ö
Doğan
Angiogenesis; Apoptosis; Bevacizumab; Endometriosis